Capillary electrophoretic separation of protease inhibitors used in human immunodeficiency virus therapy
- 10 July 2001
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 922 (1-2), 313-320
- https://doi.org/10.1016/s0021-9673(01)00890-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsAIDS, 1999
- Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and salivaJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- In VitroScreening of Nucleoside Analog Combinations for Potential Use in Anti-HIV TherapyAIDS Research and Human Retroviruses, 1997